MeSH tree: D03.383.129.799
Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart ...
Aug 5, 2026
0
7
Most breast cancers are worsened by estrogens. To combat the recurrence of these cancers, clinicians treat patients with inhibitors for estrogen production, like letrozole. But many patients do not adhere to this treatment ...
Jun 8, 2026
0
6
Macrophages, key regulators of tissue health and immune defense, are among the most abundant immune cells in solid tumors. Their role in cancer has been difficult to define because even closely related macrophage populations ...
Apr 21, 2026
0
8
Late-breaking results from the Phase III NRG GY019 trial indicate that letrozole monotherapy (L) did not demonstrate noninferiority to paclitaxel/carboplatin followed by letrozole (PC/L) for progression-free survival (PFS) ...
Apr 13, 2026
0
3
A team of Canadian scientists has uncovered a new way to slow the growth of glioblastoma, the most aggressive and currently incurable form of brain cancer—and identified an existing medication that could treat it.
Jan 21, 2026
0
33
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen treatment for women with breast cancer, a new Cambridge-led trial has found.
Jan 5, 2026
0
33
A new study reveals that a rarely-diagnosed and frequently drug-resistant species, Aspergillus tubingensis, may be one of the most common causes of fungal infections in Southern California.
Dec 5, 2025
0
13
Thrush is one of the most common infections in the world. It's caused by the fungi Candida—specifically, the yeast Candida albicans. Although yeast infections are normally treated easily with antifungal drugs, a growing number ...
Dec 1, 2025
0
16
Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical University of Munich (TUM) and Harvard Medical School have demonstrated this ...
Nov 10, 2025
0
49
Medicines containing a type of PFAS or "forever chemical" called fluorine are not leading to higher numbers of adverse drug reactions, according to new data analysis.
Sep 2, 2025
0
17
